R&D/ Video/ Views & Analysis/ Views and analysis

Millendo’s Julia Owens on leadership in rare diseases

, , , 0 Comment

Rare disease specialists Millendo Therapeutics are hoping their drug livoletide will become the first treatment for Prader-Willi syndrome.